Table 3.
Potentials of ZnONP nanocomposites on the kidney function of EAC-challenged mice
| Conjugates | Urea (mg/dl) | Creatinine (mg/dl) |
|---|---|---|
| Naive | 47.67 ± 1.52 | 0.28 ± 0.04 |
| EAC | 54.85 ± 0.63 | 0.74 ± .05a |
| DOX | 60.46 ± 2.04 | 0.78 ± 0.04a |
| ZnONPs | 66.90 ± 6.14 | 0.79 ± 0.09a |
| ZnONPs/DOX | 245.84 ± 21.29a,b,c | 0.91 ± 0.06a,b |
| ZnONPs/FA | 50.90 ± 1.05 | 0.77 ± 0.3a |
| ZnONPs/DOX/FA | 68.15 ± 1.61 | 0.48 ± 0.03a,b,c |
Data were represented as mean ± SD (n = 10). Difference between groups was considered statistically significant at P < 0.05. Note: a,b,c Statistically significant difference as compared to the corresponding means of the naive group (a), the EAC group (b), the DOX group (c)